Senataxin promotes recombination fidelity during antigen receptor gene diversification
Science Signaling · 2025
DOI: 10.1126/scisignal.adv8801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Alice Billie Libri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institut Pasteur, Université Paris Cité, INSERM U1223, Équipe Labellisée Ligue Contre Le Cancer, Genome Integrity, Immunity and Cancer Unit, 75015 Pa…. Hauptthemen laut MEDLINE: V(D)J Recombination, RNA Helicases, DNA Helicases, Receptors, Antigen, T-Cell. Die Arbeit nennt 88 Literaturangaben.
Abstract (Originalsprache)
Antigen receptor diversity depends on the assembly of variable (V), diverse (D), and joining (J) exons in genes encoding immunoglobulins (Igs) and T cell receptors (TCRs). During V(D)J recombination, DNA double-strand breaks (DSBs) introduced by the RAG1/2 nuclease complex are repaired by the process of nonhomologous end-joining (NHEJ). We hypothesized that functional redundancies between NHEJ and the chromatin DSB response, which depends on the kinase ATM, potentially masked the activity of additional factors that regulate V(D)J recombination. We performed targeted CRISPR-Cas9 knockout screens for genes implicated in V(D)J recombination in pro-B cells that were either untreated or treated with an ATM inhibitor. We found that loss of the RNA/DNA helicase senataxin (SETX) impaired V(D)J recombination and led to the formation of aberrant hybrid joints between coding ends and signal ends, both in vitro and in mice. The loss of SETX in a background deficient in the NHEJ factor XLF or in which ATM was inhibited led to substantial impairment of V(D)J recombination and to the presence of unsealed coding ends. SETX limited aberrant activation-induced cytidine deaminase (AID)–induced DNA end-joining between Igh -containing alleles during the process of class-switch recombination. Together, our findings reveal a previously uncharacterized role for SETX in promoting recombination fidelity during antigen receptor gene diversification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut Pasteur, Université Paris Cité, INSERM U1223, Équipe Labellisée Ligue Contre Le Cancer, Genome Integrity, Immunity and Cancer Unit, 75015 Paris, France.
- Department of Radiation Oncology, School of Medicine, Stanford University, CA 94305, USA.
- UK Dementia Research Institute at the University of Cambridge, Cambridge CB2 0AH, UK.
- Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, UK.
- Department of Molecular Neuroscience, Transylvanian Institute of Neuroscience, 400191 Cluj-Napoca, Romania.
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), F-67400 Illkirch, France.
ORCID-Profile: Alice Billie Libri, Jinglong Wang, Timea Marton, Wei Yu, François Dossin, Gabriel Balmus, Richard Frock, Chloé Lescale, Ludovic Deriano
Zitieren
APA
Libri, A. B., Wang, J., Marton, T., Yu, W., Dossin, F., Balmus, G., Reina-San-Martin, B., Frock, R., Lescale, C., & Deriano, L. (2025). Senataxin promotes recombination fidelity during antigen receptor gene diversification. Science Signaling. https://doi.org/10.1126/scisignal.adv8801
Vancouver
Libri AB, Wang J, Marton T, Yu W, Dossin F, Balmus G, et al. Senataxin promotes recombination fidelity during antigen receptor gene diversification. Science Signaling. 2025. doi:10.1126/scisignal.adv8801
BibTeX
@article{Libri2025,
author = {Libri, Alice Billie and Wang, Jinglong and Marton, Timea and Yu, Wei and Dossin, François and Balmus, Gabriel and Reina-San-Martin, Bernardo and Frock, Richard and Lescale, Chloé and Deriano, Ludovic},
title = {Senataxin promotes recombination fidelity during antigen receptor gene diversification},
journal = {Science Signaling},
year = {2025},
doi = {10.1126/scisignal.adv8801}
}
EUVIMED